6 studies were found.

1.		No longer recruiting	Combination Chemotherapy, Interferon alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma Conditions: Stage IV Melanoma; Recurrent Melanoma
2.		No longer recruiting	E7070 in Treating Patients With Stage IV Melanoma Conditions: Stage IV Melanoma; Recurrent Melanoma
3.		No longer recruiting	High-Dose or Low-Dose Interferon alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma Conditions: stage III melanoma; Recurrent Melanoma
4.		No longer recruiting	Interferon alfa Following Surgery in Treating Patients With Stage III Melanoma Condition: stage III melanoma
5.		No longer recruiting	Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain Conditions: Stage IV Melanoma; Recurrent Melanoma; brain metastases
6.		No longer recruiting	Vaccine Therapy in Treating Patients With Melanoma of the Eye Condition: ciliary body and choroid melanoma, medium/large size